9EMV

SARS-CoV-2 nsp10-16 methyltransferase in complex with Sangivamycin and m7GpppA (Cap0-analog)/m7GpppAm (Cap1-analog)

Summary for 9EMV

• Entry DOI: 10.2210/pdb9emv/pdb
• Related: 8BSD 8BZV 8C5M 8OSX 8OT0 8OTR 8OV1
• Descriptor: 2'-O-methyltransferase nsp16, Non-structural protein 10, SANGIVAMYCIN, ... (10 entities in total)
• Functional Keywords: methyltransferase, complex, inhibitor, viral protein
• Biological source: Severe acute respiratory syndrome coronavirus 2; More
• Total number of polymer chains: 2
• Total formula weight: 52115.27

Authors

Kremling, V.,Sprenger, J.,Oberthuer, D.,Scheer, T.E.S. (deposition date: 2024-03-11, release date: 2024-03-20)

• Primary citation: Kremling, V.,Falke, S.,Fernandez-Garcia, Y.,Ehrt, C.,Kiene, A.,Klopprogge, B.,Scheer, E.,Barthels, F.,Middendorf, P.,Kuehn, S.,Guenther, S.,Rarey, M.,Chapman, H.N.,Oberthuer, D.,Sprenger, J.; SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug development; To Be Published,

Experimental method

X-RAY DIFFRACTION (2.34 Å)